Manipulating the 4-1BB Pathway to Cure HBV

导出

摘要 Chronic Hepatitis B Virus(HBV)infection is a major global health issue leading to liver cirrhosis and hepatocellular carcinoma.Currently available treatments have limited efficacy in completely eradicating the virus.

作者 Zhang Chao Wang Fu-Sheng

机构地区 Department of Infectious Diseases

出处《Infectious Diseases & Immunity》 CSCD 2024年第4期156-157,共2页 感染性疾病与免疫（英文）

基金 supported by the National Key Research and Development Program of China(2022YFA1303600 and 2023YFC2308100) the National Natural Science Foundation of China(82130019).

关键词 CIRRHOSIS INFECTION HEPATOCELLULAR

分类号 R51 [医药卫生—内科学]

引文网络
相关文献

参考文献1

1Sheikh Mohammad Fazle Akbar,Mamun AL-Mahtab,Sakirul Khan,Osamu Yoshida,Yoichi Hiasa.“Elimination of Hepatitis by 2030”:Present Realities and Future Projections[J].Infectious Diseases & Immunity,2022,2(1):3-8. 被引量：1

二级参考文献1

1Manuel Rodríguez,Juan Manuel Pascasio,Enrique Fraga,Javier Fuentes,Martín Prieto,Gloria Sánchez-Antolín,Jose Luis Calleja,Esther Molina,María Luisa García-Buey,María Angeles Blanco,Javier Salmerón,María Lucía Bonet,Jose Antonio Pons,Jose Manuel González,Miguel Angel Casado,Francisco Jorquera,无.Tenofovir vs lamivudine plus adefovir in chronic hepatitis B:TENOSIMP-B study[J].World Journal of Gastroenterology,2017,23(41):7459-7469. 被引量：18

1Kai-Jian Chu,Yoshikuni Kawaguchi,Han Wang,Xiao-Qing Jiang,Kiyoshi Hasegawa.Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma[J].Journal of Clinical and Translational Hepatology,2024,12(2):210-217. 被引量：2
2Binyan Zhong,Shen Zhang,Haidong Zhu,Wansheng Wang,Caifang Ni,Clinical Guidelines Committee of Chinese College of Interventionalists.Transarterial chemoembolization refractoriness in hepatocellular carcinoma:Chinese College of Interventionalists definition and consensus statement[J].Chinese Medical Journal,2024,137(17):2040-2042. 被引量：1
3Lincheng Zhang,Wei Zhou,Shusen Zheng,Sunbin Ling,Xiao Xu.An E2F7/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteria[J].Chinese Medical Journal,2024,137(16):1973-1975.
4Yao Liu,Huan Feng,Qi Zhao,Xiao Liang,Ying Wang,Shuai Xiao,Suqin Shen,Jiaxue Wu.RNA binding motif protein 43(RBM43)suppresses hepatocellular carcinoma metastasis by regulating Slug mRNA stability[J].Genes & Diseases,2024,11(6):20-23.
5Xiaofeng Feng,Nafei Huang,Yuqin Wu,Fei Gao,Xiaomei Chen,Chenyi Zhang,Bing Zhang,Tao Sun.Alcoholic Liver Disease in China:A Disease Influenced by Complex Social Factors That Should Not Be Neglected[J].Journal of Clinical and Translational Hepatology,2024,12(7):677-684.
6Naweed Mohammad,Regina Oshins,Tongjun Gu,Virginia Clark,Jorge Lascano,Naziheh Assarzadegan,George Marek,Mark Brantly,Nazli Khodayari.Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease[J].Journal of Clinical and Translational Hepatology,2024,12(10):845-856.
7Silvia Ribback,Kristin Peters,Mohd Yasser,Jessica Prey,Paula Wilhelmi,Qin Su,Frank Dombrowski,Peter Bannasch.Hepatocellular Ballooning is Due to Highly Pronounced Glycogenosis Potentially Associated with Steatosis and Metabolic Reprogramming[J].Journal of Clinical and Translational Hepatology,2024,12(1):52-61.
8Yu Liu,Jiaxin Yang,Yanyan Wang,Qiqi Zeng,Yao Fan,Ailong Huang,Hui Fan.The proteasome activator subunit PSME1 promotes HBV replication by inhibiting the degradation of HBV core protein[J].Genes & Diseases,2024,11(6):395-408.
9Olivier Chatelanat,Mikaël de Lorenzi-Tognon,Laurent Spahr,Abdessalam Cherkaoui,Roger Stephan,Marie Ongaro,Laurent Kaiser,Nicolas Goossens.Liver failure after Bacillus cereus food poisoning,an underrecognized entity:A case report[J].World Journal of Hepatology,2024,16(11):1339-1347.

Infectious Diseases & Immunity

2024年第4期

浏览历史

内容加载中请稍等...

Manipulating the 4-1BB Pathway to Cure HBV

参考文献1

二级参考文献1

相关作者

相关机构

相关主题

浏览历史